Repligen Corporation Share Price
Stocks
RGEN
US7599161095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 165.18 USD | +0.30% |
|
-2.61% | +0.81% |
| 10/09 | Repligen Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 01:30 PM | |
| 09/09 | UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating | MT |
| Market Cap | 929.38Cr 800.76Cr 758.21Cr 687.24Cr 1.29TCr 89TCr 1.3TCr 9.01TCr 3.46TCr 45TCr 3.49TCr 3.41TCr 1,42700Cr | P/E 2026 * |
218x | P/E 2027 * | 95.3x |
|---|---|---|---|---|---|
| Enterprise Value | 902.89Cr 777.93Cr 736.6Cr 667.65Cr 1.25TCr 86TCr 1.26TCr 8.75TCr 3.36TCr 44TCr 3.39TCr 3.32TCr 1,38700Cr | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 9.09x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RGEN | Delayed | |
CBOE
| RGEN | Real-time | |
|
Deutsche Boerse AG
| RGN | Delayed | |
|
Börse Stuttgart
| RGN | Delayed | |
|
Tradegate
| RGN | Real-time | |
|
Boerse Muenchen
| RGN | Real-time | |
|
Berne S.E.
| RGN | End-of-day quote | |
|
Borsa Italiana
| 1RGEN | End-of-day quote |
Last Transcript : Repligen Corporation
| 1 day | +0.30% | ||
| 1 week | -2.61% | ||
| Current month | -8.73% | ||
| 1 month | +1.23% | ||
| 3 months | +26.32% | ||
| 6 months | +35.63% | ||
| Current year | +0.81% |
| 1 week | 161.14 |  | 172.94 |
| 1 month | 161.14 | | 188.73 |
| Current year | 100.99 | | 188.73 |
| 1 year | 100.99 | | 188.73 |
| 3 years | 100.99 | | 211.13 |
| 5 years | 100.99 | | 327.32 |
| 10 years | 26.16 | | 327.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Loeillot
CEO | Chief Executive Officer | 56 | 01/09/2024 |
Jason Garland
DFI | Director of Finance/CFO | 52 | 25/09/2023 |
Michael Martino
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Dawes
CHM | Chairman | 74 | 14/12/2011 |
| Director/Board Member | 60 | 12/06/2014 | |
Glenn Muir
BRD | Director/Board Member | 67 | 01/10/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Sell | Chief Executive Officer | -3,035 | 0.0054% | ||
| 01/09/26 | Tax | Controller/Auditor | -277 | 0.0005% | ||
| 20/08/26 | Exercice | Chief Executive Officer | 16,278 | 0.0288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | -2.61% | +37.39% | +2.33% | 929.38Cr | |
| -1.36% | -6.29% | -21.19% | +1.21% | 18TCr | |
| -0.72% | -2.30% | -1.47% | +13.76% | 12TCr | |
| +0.19% | -4.64% | +8.52% | +80.96% | 6.12TCr | |
| -1.92% | -7.24% | +9.51% | +41.28% | 5.02TCr | |
| +0.81% | -5.21% | -5.61% | -33.33% | 4.81TCr | |
| -1.75% | -7.45% | +9.25% | -20.43% | 3.19TCr | |
| +0.43% | -11.10% | - | - | 2.84TCr | |
| +0.58% | +1.02% | +35.66% | -11.94% | 2.42TCr | |
| +0.49% | -8.98% | -13.28% | +5.27% | 2.14TCr | |
| Average | -0.10% | -5.11% | +6.53% | +8.79% | 5.71TCr | |
| Weighted average by Cap. | -0.18% | -4.25% | -3.71% | +11.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 83Cr 71Cr 67Cr 61Cr 114.72Cr 7.9TCr 115.3Cr 801.26Cr 308.12Cr 4.02TCr 310.57Cr 303.75Cr 13TCr | 97Cr 84Cr 79Cr 72Cr 135.18Cr 9.31TCr 135.86Cr 944.15Cr 363.07Cr 4.74TCr 365.95Cr 357.92Cr 15TCr |
| Net income | 4.19Cr 3.61Cr 3.42Cr 3.1Cr 5.82Cr 400.5Cr 5.85Cr 41Cr 16Cr 203.76Cr 16Cr 15Cr 643.85Cr | 9.88Cr 8.52Cr 8.06Cr 7.31Cr 14Cr 944.28Cr 14Cr 96Cr 37Cr 480.41Cr 37Cr 36Cr 1.52TCr |
| Net Debt | -26Cr -23Cr -22Cr -20Cr -37Cr -2.53TCr -37Cr -256.65Cr -99Cr -1.29TCr -99Cr -97Cr -4.07TCr | -44Cr -38Cr -36Cr -32Cr -61Cr -4.18TCr -61Cr -424.42Cr -163.21Cr -2.13TCr -164.5Cr -160.89Cr -6.73TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $165.18 | +0.30% | 9,44,549 |
| 10/26/10 | $164.68 | -0.22% | 9,55,980 |
| 09/26/09 | $165.05 | -2.06% | 10,81,203 |
| 08/26/08 | $168.53 | +0.55% | 7,79,443 |
| 04/26/04 | $167.60 | -1.19% | 8,06,066 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RGEN Stock
Select your edition
All financial news and data tailored to specific country editions
